[B064-3]查询药物监控

{
  "data": {
    "status": 0,
    "alert_time": 20250101,
    "alert_event_data": {
      "news": [
        {
          "tag": [
            "FDA",
            "Cancer",
            "Approval"
          ],
          "url": "https://www.fda.gov/news/123456",
          "title": "FDA Approves New Cancer Drug",
          "news_id": "news_123456",
          "event_time_cn": "2024年1月15日",
          "event_time_en": "January 15, 2024",
          "event_type_cn": "新闻发布",
          "event_type_en": "News Published"
        }
      ],
      "paper": [
        {
          "url": "https://www.nature.com/articles/nm12345",
          "title": "Efficacy of Novel Drug X in Phase II Clinical Trial",
          "journal": "Nature Medicine",
          "paper_id": "paper_123456",
          "event_time_cn": "2024年1月15日",
          "event_time_en": "January 15, 2024",
          "event_type_cn": "论文发表",
          "event_type_en": "Paper Published"
        }
      ],
      "patent": [
        {
          "pn": "US10123456B2",
          "title_cn": "一种新型抗癌药物化合物",
          "title_en": "Novel Anti-cancer Drug Compound",
          "patent_id": "patent_123456",
          "event_time_cn": "2024年1月15日",
          "event_time_en": "January 15, 2024",
          "event_type_cn": "专利授权",
          "event_type_en": "Patent Granted",
          "expire_date_cn": "2030年12月31日",
          "expire_date_en": "December 31, 2030"
        }
      ],
      "news_ids": [
        "id1",
        "id2",
        "id3"
      ],
      "drug_deal": [
        {
          "url": "https://example.com/deal/123456",
          "deal_id": "deal_123456",
          "deal_title": "Pfizer Acquires Company X for $2B",
          "deal_value_cn": "20亿美元",
          "deal_value_en": "$2 billion",
          "event_type_cn": "药物交易",
          "event_type_en": "Drug Deal",
          "upfront_payment_cn": "5亿美元",
          "upfront_payment_en": "$500 million",
          "milestone_payment_cn": "15亿美元",
          "milestone_payment_en": "$1.5 billion"
        }
      ],
      "paper_ids": [
        "id1",
        "id2"
      ],
      "drug_added": [
        {
          "drug_id": "c9f0bcdf2ea7454e902b124a025bf025",
          "drug_type": [
            "1151dbc710f64a85923dc05d4a5a0ba9"
          ],
          "target_id": [
            "3d2eb481e4e6308c91f65fde3b04d000"
          ],
          "drug_id_view": {
            "drug_id": "a79be26d13cd488ca4d9cfa2234990a8",
            "display_name_cn": "瑞拉利单抗",
            "display_name_en": "Relatlimab"
          },
          "drug_type_view": [
            {
              "dict_id": "e24259c0e9fe439b8b8fb5985182a517",
              "display_name_cn": "mRNA疫苗",
              "display_name_en": "mRNA vaccine"
            }
          ],
          "target_id_view": [
            {
              "target_id": "2127d2d1ce6736a8be550cf37f0c1c63",
              "display_name_cn": "细胞程序性死亡-1",
              "display_name_en": "Programmed cell death protein 1"
            }
          ],
          "global_highest_dev_status": "b2ca28b01c34419db0365bad2f8dd09e",
          "active_org_master_entity_id": [
            "ca22cc385c771846b24b6df608005a9a"
          ],
          "global_highest_dev_status_view": {
            "dict_id": "b2ca28b01c34419db0365bad2f8dd09e",
            "display_name_cn": "临床前",
            "display_name_en": "Preclinical"
          },
          "active_org_master_entity_id_view": [
            {
              "entity_id": "ca22cc385c771846b24b6df608005a9a",
              "display_name_cn": "华东师范大学",
              "display_name_en": "East China Normal University"
            }
          ]
        }
      ],
      "event_size": 25,
      "news_count": 3,
      "patent_ids": [
        "id1",
        "id2",
        "id3",
        "id4"
      ],
      "paper_count": 2,
      "drug_missing": [
        {
          "drug_id": "c9f0bcdf2ea7454e902b124a025bf025",
          "drug_type": [
            "1151dbc710f64a85923dc05d4a5a0ba9"
          ],
          "target_id": [
            "3d2eb481e4e6308c91f65fde3b04d000"
          ],
          "drug_id_view": {
            "drug_id": "a79be26d13cd488ca4d9cfa2234990a8",
            "display_name_cn": "瑞拉利单抗",
            "display_name_en": "Relatlimab"
          },
          "drug_type_view": [
            {
              "dict_id": "e24259c0e9fe439b8b8fb5985182a517",
              "display_name_cn": "mRNA疫苗",
              "display_name_en": "mRNA vaccine"
            }
          ],
          "target_id_view": [
            {
              "target_id": "2127d2d1ce6736a8be550cf37f0c1c63",
              "display_name_cn": "细胞程序性死亡-1",
              "display_name_en": "Programmed cell death protein 1"
            }
          ],
          "global_highest_dev_status": "b2ca28b01c34419db0365bad2f8dd09e",
          "active_org_master_entity_id": [
            "ca22cc385c771846b24b6df608005a9a"
          ],
          "global_highest_dev_status_view": {
            "dict_id": "b2ca28b01c34419db0365bad2f8dd09e",
            "display_name_cn": "临床前",
            "display_name_en": "Preclinical"
          },
          "active_org_master_entity_id_view": [
            {
              "entity_id": "ca22cc385c771846b24b6df608005a9a",
              "display_name_cn": "华东师范大学",
              "display_name_en": "East China Normal University"
            }
          ]
        }
      ],
      "patent_count": 4,
      "result_count": 10,
      "drug_deal_ids": [
        "id1"
      ],
      "clinical_trial": [
        {
          "phase": {
            "dict_id": "b2ca28b01c34419db0365bad2f8dd09e",
            "display_name_cn": "临床前",
            "display_name_en": "Preclinical"
          },
          "title": "Phase II Study of Drug X in Cancer Patients",
          "event_type_cn": "临床试验",
          "event_type_en": "Clinical Trial",
          "register_number": "NCT12345678",
          "clinical_trial_id": "ct_123456",
          "clinical_result_id": "result_123456",
          "org_master_entity_id": [
            "org_001",
            "org_002"
          ],
          "org_master_entity_id_view": [
            {
              "entity_id": "ca22cc385c771846b24b6df608005a9a",
              "display_name_cn": "华东师范大学",
              "display_name_en": "East China Normal University"
            }
          ],
          "clinical_result_register_number": [
            {
              "register_number": "NCT12345678",
              "clinical_trial_id": "ct_123456"
            }
          ]
        }
      ],
      "drug_added_ids": [
        "id1",
        "id2"
      ],
      "drug_deal_count": 1,
      "drug_dev_status": [
        {
          "country": "US",
          "drug_id": "drug_123456",
          "drug_type": [
            "small_molecule"
          ],
          "target_id": "target_001",
          "dev_status": "phase_ii",
          "disease_id": "disease_001",
          "data_source": [
            {
              "source_url": "http://example.com"
            }
          ],
          "country_view": {
            "region_id": "US",
            "display_name_cn": "美国",
            "display_name_en": "United States"
          },
          "drug_id_view": {
            "drug_id": "a79be26d13cd488ca4d9cfa2234990a8",
            "display_name_cn": "瑞拉利单抗",
            "display_name_en": "Relatlimab"
          },
          "event_type_cn": "临床试验进展",
          "event_type_en": "Clinical Trial Progress",
          "drug_type_view": [
            {
              "dict_id": "e24259c0e9fe439b8b8fb5985182a517",
              "display_name_cn": "mRNA疫苗",
              "display_name_en": "mRNA vaccine"
            }
          ],
          "target_id_view": {
            "target_id": "2127d2d1ce6736a8be550cf37f0c1c63",
            "display_name_cn": "细胞程序性死亡-1",
            "display_name_en": "Programmed cell death protein 1"
          },
          "disease_id_view": {
            "disease_id": "f7ea24f0370d421480503e720310bf86",
            "display_name_cn": "食管癌",
            "display_name_en": "Esophageal Carcinoma"
          },
          "organization_id": "org_001",
          "organization_id_view": {
            "entity_id": "ca22cc385c771846b24b6df608005a9a",
            "display_name_cn": "华东师范大学",
            "display_name_en": "East China Normal University"
          }
        }
      ],
      "drug_missing_ids": [
        "id1"
      ],
      "special_approval": [
        {
          "uuid": "uuid_123456789",
          "country": "US",
          "drug_id": "drug_123456",
          "drug_type": [
            "small_molecule"
          ],
          "target_id": "target_001",
          "disease_id": "disease_001",
          "data_source": {
            "source_url": "http://example.com"
          },
          "country_view": {
            "region_id": "US",
            "display_name_cn": "美国",
            "display_name_en": "United States"
          },
          "drug_id_view": {
            "drug_id": "a79be26d13cd488ca4d9cfa2234990a8",
            "display_name_cn": "瑞拉利单抗",
            "display_name_en": "Relatlimab"
          },
          "event_type_cn": "特殊审批",
          "event_type_en": "Special Approval",
          "drug_type_view": [
            {
              "dict_id": "e24259c0e9fe439b8b8fb5985182a517",
              "display_name_cn": "mRNA疫苗",
              "display_name_en": "mRNA vaccine"
            }
          ],
          "special_review": "fast_track",
          "target_id_view": {
            "target_id": "2127d2d1ce6736a8be550cf37f0c1c63",
            "display_name_cn": "细胞程序性死亡-1",
            "display_name_en": "Programmed cell death protein 1"
          },
          "disease_id_view": {
            "disease_id": "f7ea24f0370d421480503e720310bf86",
            "display_name_cn": "食管癌",
            "display_name_en": "Esophageal Carcinoma"
          },
          "organization_id": "org_001",
          "special_review_view": {
            "dict_id": "fast_track",
            "display_name_cn": "快速通道",
            "display_name_en": "Fast Track"
          },
          "organization_id_view": {
            "entity_id": "ca22cc385c771846b24b6df608005a9a",
            "display_name_cn": "华东师范大学",
            "display_name_en": "East China Normal University"
          }
        }
      ],
      "clinical_trial_ids": [
        "id1",
        "id2"
      ],
      "result_added_count": 5,
      "drug_dev_status_ids": [
        "id1",
        "id2",
        "id3"
      ],
      "clinical_trial_count": 2,
      "result_missing_count": 2,
      "special_approval_ids": [
        "id1"
      ],
      "drug_dev_status_count": 3,
      "special_approval_count": 1,
      "translational_medicine": [
        {
          "title": "Novel Biomarker Discovery in Cancer Research",
          "journal_id": [
            "journal_001",
            "journal_002"
          ],
          "source_url": "https://example.com/source/123456",
          "event_time_cn": "2024年1月15日",
          "event_time_en": "January 15, 2024",
          "journal_id_view": [
            {
              "dict_id": "nature_medicine",
              "display_name_cn": "自然医学",
              "display_name_en": "Nature Medicine"
            }
          ],
          "translational_medicine_id": "tm_123456"
        }
      ],
      "clinical_trial_result_ids": [
        "id1"
      ],
      "translational_medicine_ids": [
        "id1"
      ],
      "translational_medicine_count": 1
    },
    "total_update_event_count": 5
  },
  "status": true,
  "error_code": 0
}